Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide vs Topiramate in Migraine
NCT06243692Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Feb 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in migraine, sponsored by Kafrelsheikh University. Started Feb 2024; status: recruiting.
02
Drugs
lacosamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06243692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243692.